More than 110 drugs, capable of penetrating this elusive barrier are currently being evaluated for the treatment of CNS disorders; there are nearly 35 technology platforms for the development of BBB penetrant drugs, claims Roots Analysis – Blogiyo
The concept of BBB penetration is anticipated to bring about a paradigm shift in modern healthcare. In fact, experts believe that there is an important relationship between the recent pandemic of Coronavirus disease (COVID-19) and cerebrovascular system, presenting commercial opportunities for players engaged in the development of BBB penetrating drugs.
The USD 940 million (by 2030) financial opportunity within the BBB market has been analyzed across the following segments:
The Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics report features the following companies, which we identified to be key players in this domain:
Market Landscape: Non-Invasive BBB Penetration
Market Landscape: BBB Penetrating Drugs
Non-Invasive BBB Penetration Technologies: Popular Approaches
Analysis of Recent Licensing Agreements
Drug Development Strategy Analysis
Market Potential of Key Neurological Disorders
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/blood-brain-barrier-drug-delivery/310.html